Michael Dybbs is Director at Dimension Therapeutics, Inc. (DMTX). They have made 1 open-market trade across 1 company since 2015, most recently 2015-10-27.
CIK 0001601264
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12.5M since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DMTX | 1,097,745 | $6.5M |
Shares reported on the most recent Form 4, priced at the 2015-10-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DMTX | BUY | 2015-10-27 | 2015-10-29 | $13.00 | $12.5M | -32.1% | -7.1% | -35.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.